Effective from 23 September, the Ministry of Health – through this Circular – has recognised the equivalence of several vaccines administered by foreign health authorities to those carried out under the National Vaccine Plan for the Prevention of SARS-CoV-2. Namely:
- Vaccines recognised by EMA – European Medicines Agency (see Annex 1 to the Circular);
- Covishield (Serum Institute of India), manufactured under license from AstraZeneca;
- R-CoVI (R-Pharm), manufactured under licence from AstraZeneca;
- Covid-19 vaccine-recombinant (Fiocruz), manufactured under licence from AstraZeneca.
As a result of this recognition:
- The above-mentioned vaccines are considered valid for the purposes of issuing the COVID-19 green certificate to Italian citizens (including those residing abroad) and their cohabiting family members, as well as to foreign citizens living in Italy for work or study and to all individuals registered in any capacity with the Italian National Health Service who have been vaccinated abroad;
- COVID-19 green certificates issued by foreign health authorities following vaccination with the above vaccines (in addition to the vaccines authorized by EMA), are considered as equivalent for all legal purposes, provided that they contain the information referred to in the said Circular (identification data of the holder, vaccine data, date(s) of administration of the vaccine, identification data of the issuer of the certificate) and are written in Italian, English, French, Spanish or German (if they are issued in another language, they must be accompanied by a sworn translation).Find travel guidance to and from foreign countries here.
